Dr Reddy’s Laboratories (DRL) plans to apply for emergency use approval (EUA) for the Russian Sputnik V from the Indian drug regulator in March and launch the vaccine around the
On the pricing front, the firm said it was discussing the Indian situation with RDIF.
First Published: Jan 30 2021 | 0:42 AM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com